Senior Scientific Director
The Lockwood Group
Senior Scientific Director
The Lockwood Group
Healthcare consulting for post-Phase II publications
About Lockwood: Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical communications. Our clients count on us to challenge their assumptions and help them creatively navigate around obstacles. From strategy through execution, we focus on accuracy, transparency, and scientific value to create programs that are evidence-based, clinically relevant, and contribute to the development of our clients’ brands. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live. Because our flexible structure provides better work-life balance, we attract the best talent, facilitate their best work, and as a result, are more responsive to our clients, wherever and whenever they do business.
Summary: In this role, the Senior Scientific Director is responsible for the planning, development, and oversight of scientific content for an assigned account or accounts across various therapeutic areas and managing most aspects of the scientific contributions across a large and/or multiple accounts..
Responsibilities: Responsibilities include leading assigned accounts, leading client interactions and brand strategy, leading the scientific portion of brand planning and business development, managing resource allocation, partnering with client services to develop SOWs and timelines and identifying areas for new and organic growth.
Education: An advanced degree in science is required.
Professional Skills & Experience:
Healthcare consulting for post-Phase II publications
The Lockwood Group is a healthcare and pharmaceutical consulting firm that helps late-stage drug developers (post-Phase 2) communicate data and prepare for market access. They provide strategic publication planning and the creation of scientifically accurate publications that meet regulatory standards, helping clients share new research with the public and stakeholders. They also offer prelaunch commercial support, identifying unmet market needs and guiding the product through launch and post-launch phases to maximize success. An affiliate, Random42, supplies medical animation to make complex scientific information visually engaging and easier to understand. The company operates on a service-based model, earning fees from project-based consulting engagements. Its goal is to support clients in delivering evidence-based, impactful communications and to enable successful market access and product launches in the competitive healthcare market.
Explore more opportunities at The Lockwood Group